Suherman Candra Maholtra 
admin 
Gilang Cahya Vitamin D Analog Shows Promise in Reprogramming the Pancreatic Tumor Microenvironment to Overcome Treatment Resistance
A small but significant clinical trial led by researchers at the Dana-Farber Cancer Institute has...
Forbion Secures Record €2.3 Billion Across Two Funds, Offering Critical Boost to European Biotech Sector
The Netherlands-based venture capital firm Forbion has successfully closed two new funds, Forbion Growth Opportunities...
Colorectal Cancer Emerges as Leading Cause of Cancer Death in Adults Under 50, Prompting Urgent Public Health Call to Action
Colorectal cancer has become the leading cause of cancer-related death among people younger than 50....
Advancing the Frontier of Pediatric Oncology: How Tailored Immunotherapies Are Revolutionizing Childhood Cancer Treatment
Over the past several decades, the landscape of childhood cancer treatment has undergone a dramatic...
Beyond the Remission: The Complex Journey of a Childhood Cancer Survivor Navigating the Intersection of Physical Recovery and Mental Health Resilience
The transition from a pediatric oncology ward back to the normalcy of adolescence is often...
MEK Identified as Key Driver of T Cell Exhaustion in Cancer Immunotherapy, Offering New Therapeutic Avenues
Lina carolina Cancer immunotherapy, a revolutionary approach that harnesses the body’s own immune system to combat malignancies,...
Beyond the Remission: How a Childhood Cancer Survivor Navigated the Invisible Crisis of Mental Health and Found Purpose in the Culinary Arts
When Cole was diagnosed with cancer at the age of 11, his immediate concerns were...
Experimental Intranasal DNA Vaccine Developed by Johns Hopkins Researchers Targets Drug-Tolerant Tuberculosis Persisters to Prevent Relapse
Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have...
Unveiling the Gut-Heart Axis: How Microbes Shape the Future of Cardiovascular Disease Prevention
Billy Candra Cardiovascular diseases (CVDs) claim nearly 20 million lives each year, making them the leading cause...
Sanofi and Regeneron Fortify Immunology Alliance with Focus on Next-Generation IL-4/IL-13 Inhibitors, Bolstering Pipeline Against Patent Expiry
Paris, France, and Tarrytown, New York – In a strategic move designed to extend their...
